Loading
BioNexus Gene Lab Corp Stock: price and insider trades · United States
US·Mcap US$3.6M
BioNexus Gene Lab Corp: what insiders have been doing
BioNexus Gene Lab Corp is a listed company. Its insiders report their share dealings to SEC (Form 4). 5 insiders have disclosed 5 filings since 26 October 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Compared with its exchange (5,813 companies, median 19 filings), a count of 5 filings is below the norm. The 10-K for the year ended 31 December 2025 shows 7.4 m USD of revenue and -3.0 m USD of net income.
There has been no open-market purchase by an insider of BioNexus Gene Lab Corp for at least a year. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
5
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 26,069 of 26,320 companies
6.7
score / 100
Value3
Quality11
FCF yld-54%
Earn yld-85%
EV/EBITDA·
ROE-34%
Gross mgn15%
Net mgn-40%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$1.22
Analyst consensus
Income statement
RevenueUS$7.4M
Gross profitUS$1.1M15% margin
EBITDA-US$2.8M-38% margin
Net income-US$3M-82.4% margin
Valuation
P/Book0.4x
Beta2.20
Balance sheet & cash
Market capUS$3.6M
Total debtUS$176k
Free Cash Flow-US$1.9M
Debt / Equity4%
Profitability & ownership
ROE-33.7%
ROA-19.0%
% insiders44.7%
% institutions0.5%
Last declaration on 14 August 2026
Declarations5 total
32,258 sharesCommon SharesSEC:0001520138-26-000347:0
16,129 sharesCommon StockSEC:0001520138-26-000345:0
96,774 sharesCommon SharesSEC:0001520138-26-000346:0
32,258 sharesCommon SharesSEC:0001520138-26-000348:0
338,709 sharesCommon SharesSEC:0001520138-26-000349:0
5 of 5 declarations
About BioNexus Gene Lab Corp
BioNexus Gene Lab Corp is a biotechnology company focused on developing innovative solutions. It is listed on the XNAS market.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
